BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8761313)

  • 1. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors.
    Schiöth HB; Chhajlani V; Muceniece R; Klusa V; Wikberg JE
    Life Sci; 1996; 59(10):797-801. PubMed ID: 8761313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
    Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
    Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the melanocortin 4 receptor by radioligand binding.
    Schiöth HB; Muceniece R; Wikberg JE
    Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
    Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.
    Schiöth HB; Muceniece R; Larsson M; Wikberg JE
    J Endocrinol; 1997 Oct; 155(1):73-8. PubMed ID: 9390008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ.
    Tatro JB; Entwistle ML
    Brain Res; 1994 Jan; 635(1-2):148-58. PubMed ID: 8173950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes.
    Schiöth HB; Muceniece R; Larsson M; Mutulis F; Szardenings M; Prusis P; Lindeberg G; Wikberg JE
    Eur J Pharmacol; 1997 Jan; 319(2-3):369-73. PubMed ID: 9042613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.
    Labbé O; Desarnaud F; Eggerickx D; Vassart G; Parmentier M
    Biochemistry; 1994 Apr; 33(15):4543-9. PubMed ID: 8161509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
    Boston BA; Cone RD
    Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
    Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
    Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
    Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
    Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of [Phe-I7], [Ala6], and [D-Ala4,Gln5,Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors.
    Schiöth HB; Muceniece R; Wikberg JE
    Peptides; 1997; 18(5):761-3. PubMed ID: 9213373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues.
    Schiöth HB; Tesfaye A; Mutulis F; Rudzish R; Mutule I; Muceniece R; Watanobe H; Wikberg JE
    Neuropeptides; 2002 Dec; 36(6):427-34. PubMed ID: 12507437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of melanocortin receptors from stingray Dasyatis akajei, a cartilaginous fish.
    Takahashi A; Davis P; Reinick C; Mizusawa K; Sakamoto T; Dores RM
    Gen Comp Endocrinol; 2016 Jun; 232():115-24. PubMed ID: 27021018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
    Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
    Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.